Trial intelligence / Profile preview

Continuous vs Intermittent Oxytocin for Labor Induction in Multiparous Women

NCT06372522Not yet recruiting

Sponsor
Rambam Health Care Campus
Start
Apr 2024
Primary completion
Apr 2026
Modality
Peptides
01

Overview

Randomised trial of oxytocin in labor induction (2 arms), sponsored by Rambam Health Care Campus. Primary endpoint: The rate of women delivering within 24 hours. Planned start Apr 2024; status: not yet recruiting.

02

Drugs

oxytocin
03

Conditions

labor induction

Beyond the preview

Go deeper on NCT06372522.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT06372522.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call